loadpatents
name:-0.051399946212769
name:-0.045793056488037
name:-0.012937068939209
Sit; Sing-Yuen Patent Filings

Sit; Sing-Yuen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sit; Sing-Yuen.The latest application filed is for "c-3 and c-17 modified triterpenoids as hiv-1 inhibitors".

Company Profile
11.42.46
  • Sit; Sing-Yuen - Wallingford CT
  • Sit; Sing-Yuen - Meriden CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
C-3 And C-17 Modified Triterpenoids As Hiv-1 Inhibitors
App 20210323997 - CHEN; Jie ;   et al.
2021-10-21
C-3 and C-17 modified triterpenoids as HIV-1 inhibitors
Grant 11,084,845 - Chen , et al. August 10, 2
2021-08-10
Aminotriazolopyridines as kinase inhibitors
Grant 10,913,738 - Guo , et al. February 9, 2
2021-02-09
Triterpenoids With Hiv Maturation Inhibitory Activity
App 20200360404 - Sit; Sing-Yuen ;   et al.
2020-11-19
Aminopyrrolotriazines As Kinase Inhibitors
App 20200347071 - Watterson; Scott Hunter ;   et al.
2020-11-05
Triterpenoids with HIV maturation inhibitory activity
Grant 10,780,102 - Sit , et al. Sept
2020-09-22
Aminotriazolopyridines As Kinase Inhibitors
App 20190389859 - Guo; Junqing ;   et al.
2019-12-26
Azadecalin derivatives as inhibitors of human immunodeficiency virus replication
Grant 10,493,070 - Chen , et al. De
2019-12-03
C-3 And C-17 Modified Triterpenoids As Hiv-1 Inhibitors
App 20190359647 - CHEN; Jie ;   et al.
2019-11-28
Aza-substituted Inhibitors Of Human Immunodeficiency Virus Replication
App 20190307776 - CHEN; Jie ;   et al.
2019-10-10
C-3 and C-17 modified triterpenoids as HIV-1 inhibitors
Grant 10,421,774 - Chen , et al. Sept
2019-09-24
Azadecalin Derivatives As Inhibitors Of Human Immunodeficiency Virus Replication
App 20190209550 - CHEN; Jie ;   et al.
2019-07-11
Triterpenoids With Hiv Maturation Inhibitory Activity
App 20190151336 - SIT; Sing-Yuen ;   et al.
2019-05-23
Triterpenoids with HIV maturation inhibitory activity
Grant 10,245,275 - Sit , et al.
2019-04-02
C-3 And C-17 Modified Triterpenoids As Hiv-1 Inhibitors
App 20190031709 - CHEN; Jie ;   et al.
2019-01-31
C17-aryl substituted betulinic acid analogs
Grant 10,047,118 - Chen , et al. August 14, 2
2018-08-14
Extended betulinic acid analogs
Grant 9,914,747 - Chen , et al. March 13, 2
2018-03-13
Triterpenoids With Hiv Maturation Inhibitory Activity
App 20170340650 - Sit; Sing-Yuen ;   et al.
2017-11-30
Extended Betulinic Acid Analogs
App 20170334945 - CHEN; Jie ;   et al.
2017-11-23
C17-aryl Substituted Betulinic Acid Analogs
App 20170305962 - CHEN; Jie ;   et al.
2017-10-26
Hepatitis C virus inhibitors
Grant 9,636,375 - Wang , et al. May 2, 2
2017-05-02
Triterpenoids With Hiv Maturation Inhibitory Activity
App 20170056420 - SIT; Sing-Yuen ;   et al.
2017-03-02
Triterpenoids with HIV maturation inhibitory activity
Grant 9,527,882 - Sit , et al. December 27, 2
2016-12-27
Compositions Having C-17 And C-3 Modified Triterpenoids With Hiv Maturation Inhibitory Activity
App 20160151387 - Regueiro-Ren; Alicia ;   et al.
2016-06-02
Hepatitis C Virus Inhibitors
App 20160067302 - Wang; Alan Xiangdong ;   et al.
2016-03-10
C-3 alkyl and alkenyl modified betulinic acid derivatives
Grant 9,249,180 - Swidorski , et al. February 2, 2
2016-02-02
Hepatitis C virus inhibitors
Grant 9,227,940 - Wang , et al. January 5, 2
2016-01-05
Triterpenoids With Hiv Maturation Inhibitory Activity
App 20150291655 - Sit; Sing-Yuen ;   et al.
2015-10-15
Hepatitis C Virus Inhibitors
App 20150005342 - Wang; Alan Xiangdong ;   et al.
2015-01-01
C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity
Grant 8,906,889 - Swidorski , et al. December 9, 2
2014-12-09
Compositions Having C-17 And C-3 Modified Triterpenoids With Hiv Maturation Inhibitory Activity
App 20140343000 - Regueiro-Ren; Alicia ;   et al.
2014-11-20
Hepatitis C virus inhibitors
Grant 8,889,871 - Wang , et al. November 18, 2
2014-11-18
C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity
Grant 8,889,854 - Sin , et al. November 18, 2
2014-11-18
C-17 and C-3 modified triterpenoids with HIV maturation inhibitory activity
Grant 8,846,647 - Regueiro-Ren , et al. September 30, 2
2014-09-30
C-3 Alkyl And Alkenyl Modified Betulinic Acid Derivatives
App 20140243298 - Swidorski; Jacob ;   et al.
2014-08-28
C-28 amides of modified C-3 betulinic acid derivatives as HIV maturation inhibitors
Grant 8,802,661 - Regueiro-Ren , et al. August 12, 2
2014-08-12
Modified C-3 betulinic acid derivatives as HIV maturation inhibitors
Grant 8,754,068 - Regueiro-Ren , et al. June 17, 2
2014-06-17
Hepatitis C Virus Inhibitors
App 20140163231 - Wang; Alan Xiangdong ;   et al.
2014-06-12
C-28 amines of C-3 modified betulinic acid derivatives as HIV maturation inhibitors
Grant 8,748,415 - Regueiro-Ren , et al. June 10, 2
2014-06-10
Hepatitis C virus inhibitors
Grant 8,710,229 - Wang , et al. April 29, 2
2014-04-29
C-17 Bicyclic Amines Of Triterpenoids With Hiv Maturation Inhibitory Activity
App 20130296554 - Sin; Ny ;   et al.
2013-11-07
Hepatitis C Virus Inhibitors
App 20130267713 - WANG; ALAN XIANGDONG ;   et al.
2013-10-10
C-3 Cycloalkenyl Triterpenoids With Hiv Maturation Inhibitory Activity
App 20130210787 - Swidorski; Jacob ;   et al.
2013-08-15
C-17 And C-3 Modified Triterpenoids With Hiv Maturation Inhibitory Activity
App 20130035318 - REGUEIRO-REN; ALICIA ;   et al.
2013-02-07
C-28 Amines Of C-3 Modified Betulinic Acid Derivatives As Hiv Maturation Inhibitors
App 20130029954 - Regueiro-Ren; Alicia ;   et al.
2013-01-31
Hepatitis C Virus Inhibitors
App 20120330019 - Wang; Xiangdong Alan ;   et al.
2012-12-27
Hepatitis C virus inhibitors
Grant 8,299,094 - Wang , et al. October 30, 2
2012-10-30
C-28 Amides Of Modified C-3 Betulinic Acid Derivatives As Hiv Maturation Inhibitors
App 20120142653 - Regueiro-Ren; Alicia ;   et al.
2012-06-07
Modified C-3 Betulinic Acid Derivatives As Hiv Maturation Inhibitors
App 20120142707 - Regueiro-Ren; Alicia ;   et al.
2012-06-07
Hepatitis C Virus Inhibitors
App 20110311482 - Wang; Xiangdong Alan ;   et al.
2011-12-22
Hepatitis C virus inhibitors
Grant 7,915,291 - Wang , et al. March 29, 2
2011-03-29
Hepatitis C virus inhibitors
Grant 7,772,180 - Sin , et al. August 10, 2
2010-08-10
Hepatitis C Virus Inhibitors
App 20090274656 - Wang; Alan Xiangdong ;   et al.
2009-11-05
Hepatitis C virus inhibitors
Grant 7,449,479 - Wang , et al. November 11, 2
2008-11-11
Hepatitis C Virus Inhibitors
App 20080119461 - Sin; Ny ;   et al.
2008-05-22
Bisarylimidazoly fatty acid amide hydrolase inhibitors
Grant RE39,634 - Sit , et al. May 15, 2
2007-05-15
3-thia-4-arylquinolin-2-one derivatives
Grant 7,179,920 - Boy , et al. February 20, 2
2007-02-20
Potassium channel modulators
Grant 7,151,180 - Hewawasam , et al. December 19, 2
2006-12-19
Chiral dinapsoline
Grant 7,091,212 - Sit August 15, 2
2006-08-15
Hepatitis C virus inhibitors
App 20060172950 - Wang; Xiangdong Alan ;   et al.
2006-08-03
3-Thia-4-arylquinolin-2-one potassium channel modulators
Grant 7,049,309 - Boy , et al. May 23, 2
2006-05-23
Hepatitis C virus inhibitors
Grant 6,995,174 - Wang , et al. February 7, 2
2006-02-07
(Oxime)carbamoyl fatty acid amide hydrolase inhibitors
Grant 6,949,574 - Sit , et al. September 27, 2
2005-09-27
3-Thia-4-arylquinolin-2-one potassium channel modulators
App 20050176763 - Boy, Kenneth M. ;   et al.
2005-08-11
(Oxime)carbamoyl fatty acid amide hydrolase inhibitors
App 20050131032 - Sit, Sing-Yuen ;   et al.
2005-06-16
Potassium channel modulators
App 20050080082 - Hewawasam, Piyasena ;   et al.
2005-04-14
3-thia-4-arylquinolin-2-one derivatives
App 20050080105 - Boy, Kenneth M. ;   et al.
2005-04-14
Hepatitis C virus inhibitors
App 20040106559 - Wang, Xiangdong Alan ;   et al.
2004-06-03
Chiral dinapsoline
App 20040063741 - Sit, Sing-Yuen
2004-04-01
Process for the preparation of dinaposoline
Grant 6,645,975 - Sit , et al. November 11, 2
2003-11-11
(Oxime)carbamoyl fatty acid amide hydrolase inhibitors
App 20030195226 - Sit, Sing-Yuen ;   et al.
2003-10-16
Bisarylimidazolyl fatty acid amide hydrolase inhibitors
App 20020188009 - Sit, Sing-Yuen ;   et al.
2002-12-12
Squarate derivatives of dihydropyridine NPY antagonists
Grant 6,432,960 - Sit , et al. August 13, 2
2002-08-13
Thiourea derivatives of dihydropyridine NPY antagonists
Grant 6,391,881 - Sit May 21, 2
2002-05-21
Alkylamine derivatives of dihydropyridine NPY antagonists
App 20020019384 - Poindexter, Graham S. ;   et al.
2002-02-14
4-Alkyl and 4-cycloalkyl derivatives of dihydropyridine NPY antagonists
App 20010049370 - Sit, Sing-Yuen
2001-12-06
Squarate derivatives of dihydropyridine NPY antagonists
App 20010047002 - Sit, Sing-Yuen ;   et al.
2001-11-29
Thiourea derivatives of dihydropyridine NPY antagonists
App 20010047003 - Sit, Sing-Yuen
2001-11-29
Dihydropyridine NPY antagonists: cyanoguanidine derivatives
Grant 6,001,836 - Poindexter , et al. December 14, 1
1999-12-14
Intermediates for the preparation of antihypercholesterolemic tetrazole compounds
Grant 4,898,949 - Wright , et al. February 6, 1
1990-02-06
Antihypercholesterolemic tetrazole compounds
Grant 4,897,490 - Sit , et al. January 30, 1
1990-01-30
Antihypercholesterolemic tetrazol-1-yl compounds
Grant 4,870,187 - Sit , et al. September 26, 1
1989-09-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed